MedSmart Group Statistics
Total Valuation
MedSmart Group has a market cap or net worth of 25,961.
| Market Cap | 25,961 |
| Enterprise Value | n/a |
Important Dates
| Earnings Date | n/a |
| Ex-Dividend Date | n/a |
Share Statistics
MedSmart Group has 51.92 million shares outstanding.
| Current Share Class | 51.91M |
| Shares Outstanding | 51.92M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | n/a |
Valuation Ratios
The trailing PE ratio is 0.00.
| PE Ratio | 0.00 |
| Forward PE | n/a |
| PS Ratio | 0.04 |
| PB Ratio | -0.01 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | 0.02 |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.03
| Current Ratio | 0.03 |
| Quick Ratio | 0.03 |
| Debt / Equity | n/a |
| Debt / EBITDA | 5.66 |
| Debt / FCF | n/a |
| Interest Coverage | 2.81 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | 126.62% |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | -5.85% |
| Weighted Average Cost of Capital (WACC) | -5.77% |
| Revenue Per Employee | 181,703 |
| Profits Per Employee | 601,469 |
| Employee Count | 4 |
| Asset Turnover | 8.66 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +49,900.00% in the last 52 weeks. The beta is -80.79, so MedSmart Group's price volatility has been lower than the market average.
| Beta (5Y) | -80.79 |
| 52-Week Price Change | +49,900.00% |
| 50-Day Moving Average | 0.05 |
| 200-Day Moving Average | 0.43 |
| Relative Strength Index (RSI) | 41.70 |
| Average Volume (20 Days) | 1,360 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 1.16 |
Income Statement
In the last 12 months, MedSmart Group had revenue of 726,811 and earned 2.41 million in profits. Earnings per share was 4.13.
| Revenue | 726,811 |
| Gross Profit | 385,778 |
| Operating Income | 170,120 |
| Pretax Income | 109,532 |
| Net Income | 2.41M |
| EBITDA | 198,827 |
| EBIT | 170,120 |
| Earnings Per Share (EPS) | 4.13 |
Balance Sheet
| Cash & Cash Equivalents | n/a |
| Total Debt | 1.12M |
| Net Cash | -1.12M |
| Net Cash Per Share | -0.02 |
| Equity (Book Value) | -2.91M |
| Book Value Per Share | -2.21 |
| Working Capital | -2.91M |
Cash Flow
| Operating Cash Flow | 1.17M |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 53.08%, with operating and profit margins of 23.41% and 15.07%.
| Gross Margin | 53.08% |
| Operating Margin | 23.41% |
| Pretax Margin | 15.07% |
| Profit Margin | 15.07% |
| EBITDA Margin | 27.36% |
| EBIT Margin | 23.41% |
| FCF Margin | n/a |
Dividends & Yields
MedSmart Group does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -7.17% |
| Shareholder Yield | -7.17% |
| Earnings Yield | 9,267.27% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on November 23, 2020. It was a reverse split with a ratio of 0.0002.
| Last Split Date | Nov 23, 2020 |
| Split Type | Reverse |
| Split Ratio | 0.0002 |
Scores
MedSmart Group has an Altman Z-Score of -312.3 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -312.3 |
| Piotroski F-Score | 6 |